StemCell Longevita is Europe's leading stem cell therapy and regenerative medicine center, headquartered in Istanbul, Turkey. With over 10 years of experience and 4,850+ international patients treated from 52+ countries, we are one of the most trusted names in mesenchymal stem cell (MSC) therapy worldwide.
Unlike many stem cell clinics that outsource cell preparation to third-party labs, StemCell Longevita operates its own GMP-certified (Good Manufacturing Practice) laboratory. This ensures complete control over stem cell quality from tissue collection to patient delivery. Our laboratory produces Wharton's jelly mesenchymal stem cells with a guaranteed 97% cell viability — significantly above the industry average of 70-80%. Every batch undergoes rigorous testing for sterility, endotoxins, mycoplasma, and cell surface markers before release for patient use.
Our multidisciplinary medical team includes specialists in regenerative medicine, neurology, cardiology, immunology, orthopedics, and hepatology. Led by Prof. Dr. Erdal Karaoz, a pioneer in stem cell research with 100+ published papers, our team designs personalized treatment protocols for each patient based on their specific condition, medical history, and treatment goals. Every treatment decision is evidence-based and informed by the latest peer-reviewed research.
We serve patients from across the globe — from the United States, United Kingdom, Germany, Netherlands, Australia, UAE, and 45+ other countries. Our international patient coordination team provides end-to-end support: medical consultation, travel planning, visa assistance, VIP airport transfers, luxury hotel accommodation, interpretation services, and 12-month post-treatment follow-up. We speak English, Dutch, Turkish, German, French, Spanish, Italian, Russian, Arabic, and Romanian.
Our transparent pricing includes everything: stem cell treatment, pre-treatment evaluation, hotel accommodation, VIP airport transfers, dedicated patient coordinator, and 12-month remote follow-up. No hidden fees, no surprises. Packages start from €5,500 — representing savings of 50-85% compared to equivalent treatments in the US, UK, or Germany.
Our treatment protocols are grounded in peer-reviewed science. We reference 30+ published clinical studies supporting MSC therapy for the conditions we treat. Our own clinical outcomes data — collected through systematic 12-month follow-up of all patients — continuously informs protocol optimization and demonstrates the real-world effectiveness of our treatments.
